Nan Shan Life Insurance’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.09M | Sell |
2,686
-2
| -0.1% | -$811 | 0.02% | 111 |
|
2025
Q1 | $1.34M | Hold |
2,688
| – | – | 0.03% | 103 |
|
2024
Q4 | $1.4M | Sell |
2,688
-50,634
| -95% | -$26.3M | 0.03% | 103 |
|
2024
Q3 | $33M | Sell |
53,322
-23,000
| -30% | -$14.2M | 0.78% | 44 |
|
2024
Q2 | $42.2M | Buy |
76,322
+5,000
| +7% | +$2.77M | 1% | 38 |
|
2024
Q1 | $41.5M | Hold |
71,322
| – | – | 0.98% | 37 |
|
2023
Q4 | $37.9M | Hold |
71,322
| – | – | 0.92% | 39 |
|
2023
Q3 | $36.1M | Buy |
71,322
+18,000
| +34% | +$9.11M | 0.98% | 40 |
|
2023
Q2 | $27.8M | Buy |
53,322
+3,883
| +8% | +$2.03M | 0.67% | 51 |
|
2023
Q1 | $28.5M | Buy |
49,439
+42,090
| +573% | +$24.3M | 0.68% | 50 |
|
2022
Q4 | $4.05M | Hold |
7,349
| – | – | 0.11% | 82 |
|
2022
Q3 | $3.73M | Sell |
7,349
-66,235
| -90% | -$33.6M | 0.09% | 86 |
|
2022
Q2 | $40M | Hold |
73,584
| – | – | 0.84% | 40 |
|
2022
Q1 | $43.5M | Hold |
73,584
| – | – | 0.76% | 41 |
|
2021
Q4 | $49.1M | Hold |
73,584
| – | – | 0.74% | 48 |
|
2021
Q3 | $42M | Hold |
73,584
| – | – | 0.7% | 47 |
|
2021
Q2 | $37.1M | Buy |
73,584
+60,454
| +460% | +$30.5M | 0.63% | 61 |
|
2021
Q1 | $5.99M | Sell |
13,130
-42,412
| -76% | -$19.4M | 0.12% | 105 |
|
2020
Q4 | $25.9M | Buy |
+55,542
| New | +$25.9M | 0.53% | 60 |
|